An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Hallux
- 08 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
- 08 Aug 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.
- 21 Jul 2016 Status changed from not yet recruiting to recruiting.